Stay updated on Daratumumab Dose Schedules in Smoldering Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Dose Schedules in Smoldering Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Dose Schedules in Smoldering Multiple Myeloma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Added a 2014 NIH grant/contract attribution and removed the related topics entries for 'Multiple myeloma' and 'MedlinePlus Genetics' from the related topics list.
    Difference
    0.2%
    Check dated 2026-08-25T19:51:05.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, signaling a minor update to the page's documentation rather than any change to the study content.
    Difference
    0.0%
    Check dated 2026-08-11T19:47:18.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The page now includes related-topic links for 'Multiple myeloma' and 'MedlinePlus Genetics'. These additions connect the study to the disease context and to authoritative patient resources.
    Difference
    0.1%
    Check dated 2026-08-04T16:51:24.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4 on the page, indicating a minor update to page metadata. No substantive study information appears to have changed.
    Difference
    0.0%
    Check dated 2026-07-21T12:50:36.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Revision: v3.6.3 is now displayed, and several related-topics entries were removed, indicating a metadata cleanup rather than substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-06-30T01:22:25.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Added the disease keyword 'Multiple myeloma' and a related topics link 'MedlinePlus Genetics' to the study page. This improves categorization and connects visitors with relevant background resources.
    Difference
    0.1%
    Check dated 2026-06-22T23:09:48.000Z thumbnail image

Stay in the know with updates to Daratumumab Dose Schedules in Smoldering Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Dose Schedules in Smoldering Multiple Myeloma Clinical Trial page.